This page is available in multiple languages
Select Language

IPO Lysogène

Back

Listing of Lysogène on Euronext

Karen Aiach, Founder and Managing Director, Lysogène, opens the trading day in Paris.

Lysogene is a biotechnology company specializing in the research and development of gene therapies for the treatment of rare neurodegenerative diseases.
The company now has 2 products in development phase for the treatment of Sanfilippo syndrom and gangliosidosis.